Investor H.C. Wainwright also gets warrants with 10% unsecured notes
By Devika Patel
Knoxville, Tenn., Aug. 9 – Oxis International, Inc. raised $250,000 in the first tranche of a $1 million private placement of unsecured convertible debentures with H.C. Wainwright & Co., LLC, according to an 8-K filed Tuesday with the Securities and Exchange Commission.
The 10% debentures are convertible into common stock at $0.40 per share. The conversion price is a 122.22% premium to $0.18, the Aug. 8 closing share price.
H.C. Wainwright also received warrants. The warrants are exercisable at $0.45, which is a 150% premium to the Aug. 8 closing price.
Located in Foster City, Calif., Oxis develops clinical and research assays, diagnostics and nutriceutical and therapeutic products.
| Issuer: | Oxis International, Inc.
|
| Issue: | Unsecured convertible debentures
|
| Amount: | $1 million
|
| Coupon: | 10%
|
| Conversion price: | $0.40
|
| Conversion premium: | 122.22%
|
| Warrants: | Yes
|
| Warrant strike price: | $0.45
|
| Investor: | H.C. Wainwright & Co., LLC
|
| Settlement date: | Aug. 9 (for $250,000)
|
| Stock symbol: | OTCBB: OXIS
|
| Stock price: | $0.18 at close Aug. 8
|
| Market capitalization: | $4.25 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
